The effect of Telmisartan on collagen biosynthesis depends on the status of estrogen activation in breast cancer cells

European Journal of Pharmacology

Volumn 628, Issue 1-3, 2010, Pages 51-56

  Kociecka, Beata ^a   Surazynski, Arkadiusz ^a   Miltyk, Wojciech ^a   Palka, Jerzy ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Breast cancer cell; Collagen; Estrogen; PPAR ; PPAR agonist

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ANGIOTENSIN 1 RECEPTOR; BETA ADRENERGIC RECEPTOR; CLOFIBRATE; COLLAGEN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; ROSIGLITAZONE; SYNAPTOPHYSIN; TELMISARTAN;

ARTICLE; BIOSYNTHESIS; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL STRAIN MCF 7; COLLAGEN SYNTHESIS; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; BENZOATES; BREAST NEOPLASMS; CELL LINE, TUMOR; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGENS; HUMANS; PPAR GAMMA;

EID: 73649111336     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.11.043     Document Type: Article

References (50)

1. Baldekas J.C., Gerstenfeld, Sonenstein G.E., and Franzblau C. Cell density and estradiol molulation of procollagen type III in cultured calf smooth muscle cells. J. Cell Biol. 257 (1982) 12262-12265
2. Benson S.C., Pershadsingh H.A., Ho C.I., Chittiboyina A., Desai P., Pravenec M., Qi N., Wang J., Avery M., and Kurtz T.W. Identification of Telmisartan as a unique angiotensisn II receptor antagonist with selective PPAR-γ modulating activity. Hypertension 43 (2004) 993-1019
3. Bishop-Bailey D., and Hla T. Endothelial cell apoptosis induced by the peroxisome proliferators-activated receptor [PPAR] ligand 15-deoxy-delta 12, 14 prostaglandin J2. J Biol. Chem. 274 (1999) 17042-17048
4. Carey D.J. Control of growth and differentiation of vascular cells by extracellular matrix. Annu. Rev. Physiol. 53 (1991) 161-177
5. Castello L., Froio T., Cavallini G., Biasi F., Sapino A., Leonarduzzi G., Bergamini E., Poli G., and Chiarpotto E. Calorie restriction protects against age-related rat aorta sclerosis. FASEB J. 19 (2005) 1863-1865
6. Conner P., Lundström E., and von Schoultz B. Breast cancer and hormonal therapy. Clin. Obstet. Gynecol. 51 (2008) 592-606
7. Cordera F., and Jordan V.C. Steroid receptors and their role in the biology and control of breast cancer growth. Semin. Oncol. 33 (2006) 631-641
8. Devleeschouwer N., Body J.J., Legros N., Muquardt C., Donnay I., Wouters P., and Leclercq G. Growth factor-like activity of phenol red preparations in the MCF-7 breast cancer cell line. Anticancer Res. 12 (1992) 789-794
9. D'Hooghe T.M. Immunomodulators and aromatase inhibitors: are they the next generation of treatment for endometriosis?. Curr. Opin. Obstet. Gynecol. 15 (2003) 243-249
10. Dickson R.B., and Lippman M.E. Control of human breast cancer by estrogen, growth factors, and oncogenes. Cancer Treat. Res. 40 (1988) 119-165
11. Dickson R.B., and Lippman M.E. Breast cancer. In: Dickson R.P., and Lippman M.E. (Eds). Cellular and Molecular Biology (1988), Kluwer, Boston 119-165
12. Edelman G.M., and Crossin K.L. Cell adhesion molecules: implications for a molecular histology. Annu. Rev. Biochem. 60 (1990) 155-190
13. Glass C.K. Going nuclear in metabolic and cardiovascular disease. J. Clin. Invest. 116 (2006) 556-560
14. Grommes C., Landreth G.E., and Heneka M.T. Antineoplastic effects of peroxisome proliferators-activated receptor-gamma agonists. Lancet Oncol. 5 (2004) 419-429
15. Gronemeyer H., Gustafsson J.A., and Laudet V. Principles for modulation of the nuclear receptor superfamily. Nat. Rev. Drug Discov. 3 (2004) 950-964
16. Guan H.P., Ishizuka T., Chui P.C., Lehrke M., and Lazar M.A. Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes. Genes Dev. 19 (2005) 453-461
17. Houseknecht K.L., Cole B.M., and Steele P.J. Peroxisome proliferator-activated receptor-gamma [PPAR-gamma] and its ligands: a review. Domest. Anim. Endocrinol. 22 (2002) 1-23
18. Hynes R.O. Integrins: a family of cell surface receptors. Cell 48 (1987) 549-554
19. Hynes R.O. Integrins: versitility, modulatin and signaling in cell adhesion. Cell 69 (1992) 11-25
20. Jordan V.C. Overview from the International Conference on Long-Term Tamoxifen Therapy for Breast Cancer. J. Natl. Cancer Inst. 84 (1992) 231-234
21. Juliano R.L., and Haskill S. Signal transduction from the extracellular matrix. J. Cell Biol. 120 (1993) 577-585
22. Juliano R.L., and Varner J.A. Adhesion molecules in cancer: the role of integrins. Curr. Opin. Cell. Biol. 5 (1993) 812-818
23. Keller H., Givel F., Perroud M., and Wahli W. Signaling cross-talk between peroxisome proliferator-activated receptor/retinoid X receptor and estrogen receptor through estrogen response elements. Mol. Endocrinol. 9 (1995) 794-804
24. Kouba D.J., Chung K.Y., Nishiyama T., Vindevoghel L., Kon A., Klement J.F., Uitto J., and Mauviel A. Nuclear factor-kappa B mediates TNF-alpha inhibitory effect on alpha 2[I] collagen [COL1A2] gene transcription in human dermal fibroblasts. J. Immunol. 162 (1999) 4226-4234
25. Kumar A., Takada Y., Boriek A.M., and Aggarwal B.B. Nuclear factor-B: its role in health and disease. J. Mol. Med. 82 (2004) 434-448
26. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
27. Lee H., and Bai W. Regulation of estrogen receptor nuclear export by ligand-induced and p-38-mediated receptor phosphorylation. Mol. Cell. Biol. 22 (2002) 5835-5845
28. Lerner L.J., and Jordan V.C. Development of antiestrogens and their use in breast cancer: Eighth Cain memorial award lecture. Cancer Res. 50 (1990) 4177-4189
29. Liotta L.A. Tumor invasion and metastases - role of the extracellular matrix. Cancer Res. 46 (1986) 1-7
30. Liotta L.A., and Kohn E. Cancer invasion and metastates. JAMA 263 (1990) 1123-1161
31. Livasy C.A., Karaca G., Nanda R., Tretiakova M.S., Olopade O.I., Moore D.T., and Perou C.M. Phenotypic evaluation of the basal-loke subtype of invasive breast carcinoma. Mod. Pathol. 19 (2006) 264-271
32. Miltyk W., Anchim T., Wolczynski S., and Palka J. Estrogen-dependent regulation of prolidase activity in breast cancer MCF-7 cells. Gynecol. Endocrinol. 13 (1999) 166-174
33. Miltyk W., Karna E., and Palka J.A. Prolidase-independent mechanism of camptothecin-induced inhibition of collagen biosynthesis in cultured human skin fibroblasts. J. Biochem. 141 (2007) 287-292
34. Mueller E., Drori S., Aiyer A., Yie J., Sarraf P., Chen H., Hauser S., Rosen E.D., Ge K., Roeder R.G., and Spiegelman B.M. Genetic analysis of adipogenesis through peroxisome proliferator-activated receptor gamma isoforms. J. Biol. Chem. 277 (2002) 41925-41930
35. Osborne C.K., Yochmowitz M.G., Knight W.A., and McGuire W.L. The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46 (1980) 2884-2888
36. Osborne C.K., Hobbs K., and Clark G.M. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res. 45 2 (1985) 584-590
37. Peterkofsky B., Chojkier M., and Bateman J. Determination of collagen synthesis in tissue and cell culture system. In: Furthmay M. (Ed). Immunochemistry of the Extracellular Matrix (1982) 19-47
38. Price J.E., Polyzos A., Zhang R.D., and Daniel L.M. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res. 50 (1990) 717-721
39. Rippe R.A., Schrum L.W., Stefanovic B., Solis-Herruzo J.A., and Brenner D.A. NF-kappaB inhibits expression of the alpha1[I] collagen gene. DNA Cell Biol. 18 (1999) 751-761
40. Ruoslahti E. Control of cell motility and tumor invasion by extracellular matrix interaction. Br. J. Cancer 66 (1992) 239-242
41. Schmid M.E.C., and Froesch E.R. Enhanced osteoblast proliferation and collagen gene expression by estradiol. Proc. Nat. Acad. Sci. USA 85 (1988) 2307-2310
42. Smith C.L. Cross-talk between peptide growth factor and estrogen signaling pathways. Biol. Rep. 58 (1998) 627-632
43. Streuli C.H., and Bissell M.J. Expression of extracellular matrix components is regulated by substratum. J. Cell Biol. 110 (1990) 1405-1415
44. Surazynski A., Jarzabek K., Haczynski J., Laudanski P., Palka J., and Wolczynski S. Differential effects of estradiol and raloxifene on collagen biosynthesis in cultured human skin fibroblasts. Int. J. Mol. Med. 12 (2003) 803-809
45. Surazynski A., Sienkiewicz P., Wołczyński S., and Pałka J. Differential effects of echistatin and thrombin on collagen production and prolidase activity in human dermal fibroblasts and their possible implication in β1-integrin-mediated signaling. Pharmacol. Res. 51 (2005) 217-221
46. Tharaux P.L., Chatziantoniou C., Fakhouri F., and Dussaule J.C. Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER kinase pathway. Hypertension 36 (2000) 330-336
47. Tsai M.J., and O'Malley B.W. Molecular mechanism of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63 (1994) 451-486
48. Wang T., Xu J., Yu X., Yang R., and Chao Han Z. Peroxisome proliferator-activated receptor-γ in malignant diseases. Crit. Rev. Oncol./Hematol. 58 (2006) 1-14
49. Willson T.M., Brown P.J., Sternbach D.D., and Henke B.R. The PPARs: from orphan receptors to drug discovery. J. Med. Chem. 43 (2000) 527-550
50. Zusman S., Patel-King R.S., French-Constant C., and Hynes R.O. Requirements 108 (1990) 391-402